financial_disclosure

Beverly, Mass. – September 11, 2026 -- Axcelis Technologies (Nasdaq: ACLS) will invest $35 million to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea, with production slated to begin in the second half of 2028.

Axcelis expands Korean manufacturing footprint with 200,000-square-foot plant

The Pyeongtaek site will span approximately 200,000 square feet of gross floor area, integrating warehousing, Class 1,000 and Class 10,000 cleanrooms, and a dedicated training center. The company said the design draws on nearly 50 years of semiconductor capital equipment manufacturing experience to create a lean production environment aimed at faster, more flexible customer response.

Beijing – September 11, 2026 -- Waterdrop Inc. (NYSE: WDH) reported second-quarter 2026 operating revenue of RMB1,448.2 million, up 72.8% year-over-year, with net profit attributable to ordinary shareholders reaching RMB125.8 million, marking the company's 18th consecutive profitable quarter.

The Beijing-based insurance and healthcare technology firm has cumulatively repurchased approximately 62.9 million American Depositary Shares from the open market as of August 31, 2026.

Insurance revenue climbs 80.5% as AI tools drive premium growth

Insurance-related revenue rose 80.5% year-over-year, with operating profit for the segment reaching RMB183.6 million, up 20% quarter-over-quarter. Premiums facilitated through the company's 'AI Medical Insurance Expert' tool increased 25.6% quarter-over-quarter, while first-year premiums for long-term insurance products grew 33.4% quarter-over-quarter.

Washington – September 11, 2026 -- Quantinuum has finalized a $100 million funding agreement with the U.S. Department of Commerce's CHIPS Research and Development Office, marking the first CHIPS for R&D award granted to a trapped-ion quantum computing architecture company.

Federal grant follows May letter of intent to fund quantum semiconductor manufacturing

The award, managed through the CHIPS and Science Act, finalizes a letter of intent announced in May 2026. The funding targets research, development and manufacturing capabilities for quantum semiconductors required to deploy fault-tolerant, large-scale trapped-ion quantum computers in the United States.

Washington – September 11, 2026 -- Quantinuum has finalized a $100 million federal funding agreement with the US Department of Commerce's CHIPS Research and Development Office, backing domestic manufacturing of trapped-ion quantum computers under the CHIPS and Science Act. The award follows a letter of intent announced in May and makes Quantinuum the only trapped-ion architecture company to receive CHIPS R&D funding.

Federal grant targets fault-tolerant quantum hardware supply chain

The funding will support R&D and manufacturing capacity for quantum semiconductors required to scale trapped-ion quantum computers to fault-tolerant levels. Quantinuum said the grant will help diversify its supply chain by integrating domestic partners GlobalFoundries and Monarch Quantum into its production process.

Juno Beach, Fla. – September 11, 2026 -- NextEra Energy, Inc. (NYSE: NEE) and the U.S. Department of Energy's Office of Energy Dominance Financing have reached financial close on a loan of up to $1.9 billion to restart the Duane Arnold Energy Center, Iowa's only nuclear plant.

Loan closes conditional financing for 615-megawatt Linn County reactor

The Duane Arnold facility, which operated for more than four decades before shutting down in 2020, is targeted for restart no later than the first quarter of 2029, pending regulatory approvals. NextEra first announced restart plans in October 2025.

San Diego – September 11, 2026 -- Inhibrx Biosciences reported that its OX40 agonist INBRX-106, combined with pembrolizumab, produced a 48.3% confirmed objective response rate in first-line head and neck squamous cell carcinoma patients, nearly double the 26.5% seen with pembrolizumab alone.

Phase 2 data show the combination therapy nearly doubles response rates versus standard treatment

The randomized Phase 2 portion of the HexAgon study enrolled 68 patients across more than 80 sites in the United States, Europe and Asia, with 63 evaluable for the primary endpoint. Four patients (13.8%) on the combination arm achieved complete responses, compared with zero in the pembrolizumab-only control arm. Six-month progression-free survival reached 72.4% for the combination versus 42.8% for monotherapy, with median PFS of 9.6 months versus 4.9 months as of the August 19, 2026 data cutoff.

Reston, Va. – September 11, 2026 -- V2X, Inc. (NYSE: VVX) has secured a $19 million indefinite-delivery/indefinite-quantity contract from the U.S. Marine Corps to supply its Tempest counter-Unmanned Aerial System (C-UAS) vehicles.

Contract covers vehicles, maintenance and training support

Under the agreement, V2X will deliver Tempest vehicles alongside maintenance support, software management, spares, ancillary components, training, and engineering services. The Tempest platform is designed to detect, track, and defeat unmanned aerial threats while maintaining mobility to reposition alongside maneuver forces.

Hong Kong – September 11, 2026 -- SANY Heavy Industry (600031.SH) posted H1 2026 revenue of approximately USD 7.89 billion, up 19.49% year over year, with attributable net profit rising 9.13% to USD 838.887 million.

Q2 growth outpaces first-half rate as overseas revenue crosses 61% of core business

Second-quarter revenue climbed 24.39% to USD 4.328 billion, exceeding the H1 growth pace, while attributable net profit for the quarter rose 16.93% to USD 473.108 million. Operating cash flow reached USD 1.440 billion. As of June 30, total assets stood at USD 26.708 billion and shareholders' equity at USD 13.576 billion.

London – September 11, 2026 -- Brightstar Lottery PLC (NYSE: BRSL) launched a tender offer for any and all Regulation S interests in its outstanding €500,000,000 2.375% Senior Secured Notes due 2028, offering holders €990.00 per €1,000 in nominal value plus accrued interest.

Brightstar plans a new euro-denominated benchmark bond due 2032 to fund the buyback

The company simultaneously announced a benchmark offering of euro-denominated senior secured notes due 2032, guaranteed on a senior basis by certain wholly-owned subsidiaries. Brightstar has applied to list the new notes on the Official List of Euronext Dublin and admit them to trading on the Global Exchange Market. Completion of the new bond sale is a condition to the tender offer, though Brightstar retains sole discretion to waive that requirement.

Wiesbaden – September 11, 2026 -- German exports declined 0.8% month-on-month in July 2026 to a calendar- and seasonally-adjusted €138.2 billion, while imports dropped sharply by 5.7% to €116.9 billion, according to preliminary data from the Federal Statistical Office (Destatis).

The trade surplus widened to €21.3 billion in July, up from €15.4 billion in June, though below the €16.8 billion recorded in July 2025. Year-on-year, exports rose 6.1% and imports climbed 3.0% compared with July 2025.

US-bound shipments surge 19.1% month-on-month to €14.4 billion

German exports to the United States jumped 19.1% versus June and were up 28.3% from July 2025, making the US the top destination for German goods. Exports to the United Kingdom fell 7.2% to €6.7 billion, while shipments to China dropped 9.5% to €5.6 billion.